Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men

American Journal of Cardiology

Volumn 84, Issue 9, 1999, Pages 1018-1022

  Rohde, Luis E P ^a   Hennekens, Charles H ^b   Ridker, Paul M ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Division of Preventive Medicine   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; D DIMER; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LIPOPROTEIN A; TISSUE PLASMINOGEN ACTIVATOR DERIVATIVE; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; EXERCISE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; BETA CAROTENE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; DOUBLE-BLIND METHOD; HUMANS; LIPIDS; MALE; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS;

EID: 0032720533     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00491-9     Document Type: Article

References (22)

1. Liuzzo G., Biazucci L.M., Gallmore R., Grillo R.L., Rebuzzi A.G., Pepys M.B., Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 331:1994;417-424.
2. Thompson S.G., Kienast J., Pyke S.D.M., Haverkate F., van de Loo J.C.W. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 332:1995;635-641.
3. Harverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., Pepys M.G. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action in Thrombolisis and Disabilities Angina Pectoris Study Group. Lancet. 349:1997;462-466.
4. Kuller L.H., Tracy R.P., Shaten J., Meinhahn E.N. Relation of C-reactive protein and coronary artery disease in the MRFIT nested case-control study. Am J Epidemiol. 144:1996;537-547.
5. Tracy R.P., Lemaitre R.N., Psaty B.M., Ives D.G., Evans R.W., Cushman M., Meilahn E.N., Kuller L.H. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly results from the Cardiovascular Health Study and the Rural Health Promotion Project . Arterioscler Thromb Vasc Biol. 17:1997;1121-1127.
6. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and risks of cardiovascular disease in apparently healthy men. N Engl J Med. 336:1997;973-979.
7. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 97:1998;425-428.
8. Ridker P.M., Buring J.E., Shih J., Matias M., Hennekens C.H. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 98:1998;731-733.
9. Ridker P.M., Glynn R.J., Hennekens C.H. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 97:1998;2007-2011.
10. Morrow D.A., Rifai N., Antman E., Weiner Dl, McCabe C.H., Cannon C.P., Braunwald E. C-reactive protein is a potent predictor of mortality independent of and in combination with Troponin T in acute ischemic syndromes. J Am Coll Cardiol. 31:1998;1449-1454.
11. Ridker P.M., Rifai N., Pfeffer M.A., Sacks F.M., Moye L.A., Goldman S., Flaker G.C., Braunwald E. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation. 98:1998;839-844.
12. Mendall M.A., Patel P., Ballam L., Strachan D., Northfield T.C. C-reactive protein and its relation to cardiovascular risk factors a population based cross section study . Br Med J. 312:1996;1061-1064.
13. Tracy R.P., Psaty B.M., Macy E., Bovill E.G., Cushman M., Cornell E.S., Kuller L.H. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol. 17:1997;2167-2176.
14. Final Report of the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 321:1989;129-135.
15. Macy E.M., Hayes T.E., Tracy R.P. Variability in the measurement of C-reactive protein in healthy subjects implications for reference interval and epidemiological applications . Clin Chem. 43:1997;52-58.
16. Stampfer M.J., Sacks F.M., Salvini S., Willet W.C., Hennekens C.H. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 325:1991;373-381.
17. Ridker P.M., Hennekens C.H., Selhub J., Miletich J.P., Malinow M.R., Stampfer M.J. Interrelation of hypermocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation. 95:1997;1777-1782.
18. Ridker P.M., Hennekens C.H., Stampfer M.J. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA. 270:1993;2195-2199.
19. Ridker P.M., Vaughan D.E., Stampfer M.J., Manson J.E., Hennekens C.H. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet. 341:1993;1165-1168.
20. Tisi P.V., Hulse M., Chulakadabba A., Gosling P., Shearman C.P. Exercise training for intermittent claudication does it adversely affect biochemical markers of the exercise-induced inflammatory response? Eur J Vasc Endovasc Surg. 14:1997;344-350.
21. Calles-Escandon J., Ballor D., Harvey-Berino J., Ades P., Tracy R., Sobel B. Amelioration of the inhibition of fibrinolysis in elderly, obese subjects by moderate energy intake restriction. Am J Clin Nutr. 64:1996;7-11.
22. Schultz D.R., Arnold P.I. Properties of four acute phase proteins C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen . Semin Arthritis Rheum. 20:1990;129-147.